Pfizer's Big Year
This article was originally published in RPM Report
Executive Summary
Pfizer expects as many as six new drug approvals in 2006. That will go a long way towards helping increase the overall new drug approval total for the year. But it doesn't mean Pfizer's R&D engine is running better than anyone else's.